255 related articles for article (PubMed ID: 30712836)
1. Interventions to improve oral vaccine performance: a systematic review and meta-analysis.
Church JA; Parker EP; Kirkpatrick BD; Grassly NC; Prendergast AJ
Lancet Infect Dis; 2019 Feb; 19(2):203-214. PubMed ID: 30712836
[TBL] [Abstract][Full Text] [Related]
2. Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis.
Macklin GR; Grassly NC; Sutter RW; Mach O; Bandyopadhyay AS; Edmunds WJ; O'Reilly KM
Lancet Infect Dis; 2019 Oct; 19(10):1121-1128. PubMed ID: 31350192
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).
Cowley D; Sari RM; Handley A; Watts E; Bachtiar NS; At Thobari J; Satria CD; Bogdanovic-Sakran N; Nirwati H; Orsini F; Lee KJ; Kirkwood CD; Soenarto Y; Bines JE
Vaccine; 2019 Nov; 37(49):7233-7239. PubMed ID: 31607604
[TBL] [Abstract][Full Text] [Related]
4. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
[TBL] [Abstract][Full Text] [Related]
5. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
6. Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants.
Church JA; Chasekwa B; Rukobo S; Govha M; Lee B; Carmolli MP; Ntozini R; Mutasa K; McNeal MM; Majo FD; Tavengwa NV; Kirkpatrick BD; Moulton LH; Humphrey JH; Prendergast AJ
Vaccine; 2020 Mar; 38(13):2870-2878. PubMed ID: 32088018
[TBL] [Abstract][Full Text] [Related]
7. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines.
Patel M; Steele AD; Parashar UD
Vaccine; 2012 Apr; 30 Suppl 1():A30-5. PubMed ID: 22520134
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
De Coster I; Leroux-Roels I; Bandyopadhyay AS; Gast C; Withanage K; Steenackers K; De Smedt P; Aerssens A; Leroux-Roels G; Oberste MS; Konopka-Anstadt JL; Weldon WC; Fix A; Konz J; Wahid R; Modlin J; Clemens R; Costa Clemens SA; Bachtiar NS; Van Damme P
Lancet; 2021 Jan; 397(10268):39-50. PubMed ID: 33308429
[TBL] [Abstract][Full Text] [Related]
9. Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.
Emperador DM; Velasquez DE; Estivariz CF; Lopman B; Jiang B; Parashar U; Anand A; Zaman K
Clin Infect Dis; 2016 Jan; 62(2):150-6. PubMed ID: 26349548
[TBL] [Abstract][Full Text] [Related]
10. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
Baker JM; Tate JE; Leon J; Haber MJ; Lopman BA
PLoS Med; 2019 Dec; 16(12):e1003005. PubMed ID: 31887139
[TBL] [Abstract][Full Text] [Related]
11. Experience with registered mucosal vaccines.
Dietrich G; Griot-Wenk M; Metcalfe IC; Lang AB; Viret JF
Vaccine; 2003 Jan; 21(7-8):678-83. PubMed ID: 12531339
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of three sequential schedules with Sabin inactivated poliovirus vaccine and bivalent oral poliovirus vaccine in Zhejiang, China: an open-label, randomised, controlled trial.
He H; Wang Y; Deng X; Yue C; Tang X; Li Y; Liu Y; Yin Z; Zhang G; Chen Z; Xie S; Wen N; An Z; Chen Z; Wang H
Lancet Infect Dis; 2020 Sep; 20(9):1071-1079. PubMed ID: 32442523
[TBL] [Abstract][Full Text] [Related]
13. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.
Cryz SJ; Que JU; Levine MM; Wiedermann G; Kollaritsch H
Infect Immun; 1995 Apr; 63(4):1336-9. PubMed ID: 7890391
[TBL] [Abstract][Full Text] [Related]
15. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial.
Ali A; Kazi AM; Cortese MM; Fleming JA; Moon S; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi AK
PLoS One; 2015; 10(6):e0127622. PubMed ID: 26035743
[TBL] [Abstract][Full Text] [Related]
16. The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems.
Kirkpatrick BD; Colgate ER; Mychaleckyj JC; Haque R; Dickson DM; Carmolli MP; Nayak U; Taniuchi M; Naylor C; Qadri F; Ma JZ; Alam M; Walsh MC; Diehl SA; ; Petri WA
Am J Trop Med Hyg; 2015 Apr; 92(4):744-51. PubMed ID: 25711607
[TBL] [Abstract][Full Text] [Related]
17. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
Sáez-Llorens X; Bandyopadhyay AS; Gast C; Leon T; DeAntonio R; Jimeno J; Caballero MI; Aguirre G; Oberste MS; Weldon WC; Konopka-Anstadt JL; Modlin J; Bachtiar NS; Fix A; Konz J; Clemens R; Costa Clemens SA; Rüttimann R
Lancet; 2021 Jan; 397(10268):27-38. PubMed ID: 33308427
[TBL] [Abstract][Full Text] [Related]
19. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group.
Rennels MB; Ward RL; Mack ME; Zito ET
J Infect Dis; 1996 Feb; 173(2):306-13. PubMed ID: 8568290
[TBL] [Abstract][Full Text] [Related]
20. Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial.
Mir F; Quadri F; Mach O; Ahmed I; Bhatti Z; Khan A; Rehman NU; Durry E; Salama M; Oberste SM; Weldon WC; Sutter RW; Zaidi AK
Lancet Infect Dis; 2015 Aug; 15(8):889-97. PubMed ID: 26093979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
